Product
BRII-196/BRII-198
1 clinical trial
1 indication
Indication
COVID-19Clinical trial
A Multicenter, Adaptive, Randomized, Blinded Controlled Trial of the Safety and Efficacy of Investigational Therapeutics for Hospitalized Patients With COVID-19Status: Completed, Estimated PCD: 2022-04-06